- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials Sponsored by Austrian Breast Cancer Study Group
Total 406 results
-
Austrian Breast & Colorectal Cancer Study GroupPharmacia Austria GmbHCompletedBreast CancerAustria
-
Austrian Breast & Colorectal Cancer Study GroupCompletedColorectal CarcinomaAustria
-
Austrian Breast & Colorectal Cancer Study GroupCompleted
-
Austrian Breast & Colorectal Cancer Study GroupCompleted
-
Austrian Breast & Colorectal Cancer Study GroupTerminatedRectal Cancer Dukes B, Dukes CAustria
-
Austrian Breast & Colorectal Cancer Study GroupCompletedColon Cancer Stage IIIAustria
-
Austrian Breast & Colorectal Cancer Study GroupMerck Gesellschaft mbH, AustriaTerminatedColorectal Cancer | SteatohepatitisAustria
-
Austrian Breast & Colorectal Cancer Study GroupAstraZenecaCompleted
-
Austrian Breast & Colorectal Cancer Study GroupAstraZenecaCompletedRandomized Study Comparing CMF and Goserelin + Tamoxifen in Premenopausal Receptor-positive PatientsEarly-stage Breast Cancer
-
German Breast GroupNovartis Pharmaceuticals; Austrian Breast & Colorectal Cancer Study GroupCompletedBreast CancerGermany, Austria
-
Austrian Breast & Colorectal Cancer Study GroupOberösterreichische KrebshilfeRecruitingColorectal CarcinomaAustria
-
AmgenAustrian Breast and Colorectal Cancer Study GroupCompletedBreast CancerAustria, Sweden
-
Karolinska University HospitalGerman Breast Group; Austrian Breast & Colorectal Cancer Study Group; Swedish...UnknownBreast CancerSweden, Germany, Austria
-
Austrian Breast & Colorectal Cancer Study GroupHoffmann-La Roche; Merck Gesellschaft mbH, AustriaCompleted
-
AstraZenecaAustrian Breast and Colorectal Cancer Study Group (ABCSG)RecruitingBreast Cancer, Early Breast CancerUnited States, Spain, Italy, Belgium, Canada, Korea, Republic of, Portugal, France, United Kingdom, China, Germany, Japan, Mexico, Thailand, Australia, Austria, Brazil, Colombia, Taiwan, Malaysia, Philippines, Poland, Romania, Chile, Sw... and more
-
Austrian Breast & Colorectal Cancer Study GroupHoffmann-La RocheCompleted
-
Austrian Breast & Colorectal Cancer Study GroupAstraZeneca; Novartis PharmaceuticalsCompletedBreast CancerAustria, Germany
-
Austrian Breast & Colorectal Cancer Study GroupHoffmann-La RocheTerminated
-
Austrian Breast & Colorectal Cancer Study GroupHoffmann-La Roche; CephalonCompleted
-
Korean Breast Cancer Study GroupUnknown
-
Korean Breast Cancer Study GroupUnknownBreast CancerKorea, Republic of
-
Korean Breast Cancer Study GroupUnknownRecurrent Breast CancerKorea, Republic of
-
Korean Breast Cancer Study GroupUnknownBreast CancerKorea, Republic of
-
Korean Breast Cancer Study GroupUnknownBreast Cancer Stage II | Breast Cancer Stage IIIKorea, Republic of
-
Korean Breast Cancer Study GroupUnknownBreast CancerKorea, Republic of
-
Korean Breast Cancer Study GroupUnknownMetastatic Breast CancerKorea, Republic of
-
Korean Breast Cancer Study GroupUnknownMetastatic Breast Cancer | Recurrent Breast CancerKorea, Republic of
-
Korean Breast Cancer Study GroupUnknownBreast CancerKorea, Republic of
-
Austrian Hernia Study GroupTerminatedObesity | Incisional HerniaAustria
-
Austrian Breast & Colorectal Cancer Study GroupHoffmann-La Roche; Sanofi-SynthelaboCompleted
-
China Breast Cancer Clinical Study GroupUnknown
-
German Breast GroupAGO Study GroupCompleted
-
Genentech, Inc.Breast International Group; SOLTI Breast Cancer Research Group; Austrian Breast...CompletedBreast CancerUnited States, United Kingdom, Germany, Australia, Austria, Belgium, Brazil, France, Guatemala, Italy, Korea, Republic of, Panama, Poland, Portugal, Spain, Czechia, Hungary, Mexico, Peru, Switzerland, El Salvador, Chile
-
German Breast GroupAGO Study GroupCompleted
-
Samsung Medical CenterKorean Breast Cancer Study GroupRecruitingBreast CancerKorea, Republic of
-
Asan Medical CenterKorean Breast Cancer Study GroupUnknownBreast CancerKorea, Republic of
-
German Breast GroupGilead Sciences; ETOP IBCSG Partners Foundation; UNICANCER; Austrian Breast & Colorectal... and other collaboratorsRecruitingTriple Negative Breast Cancer | HER2-negative Breast CancerSpain, France, Germany, Austria, Belgium, Ireland, Italy, Switzerland
-
University Hospital, Basel, SwitzerlandETOP IBCSG Partners Foundation; Austrian Breast Cancer Study GroupRecruitingNode-positive Breast CancerGreece, Switzerland, Hungary, Austria, Germany, Italy, Lithuania, Argentina, Croatia
-
Alliance Foundation Trials, LLC.Pfizer; Breast International Group; NSABP Foundation Inc; Austrian Breast & Colorectal... and other collaboratorsActive, not recruitingBreast CancerUnited States, Spain, Italy, Ireland, United Kingdom, Australia, Germany, Japan, Portugal, Taiwan, Canada, Israel, Netherlands, Switzerland, Belgium, Austria, Hungary, Korea, Republic of, Mexico, Poland, Sweden
-
Austrian Breast & Colorectal Cancer Study GroupSanofi; Hoffmann-La Roche; Amgen; Ebewe Pharma GmbHCompleted
-
German Breast GroupPfizer; AGO Study Group; Breast International Group; NSABP Foundation IncCompletedBreast Cancer | Hormonreceptor Positive | Her2-normal | Postneoadjuvant Treatment With CDK 4/6 Inhibitor | CPS-EG ScoreUnited States, Australia, Austria, Canada, France, Germany, Ireland, Japan, Korea, Republic of, Spain, United Kingdom
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI); Austrian Breast & Colorectal Cancer Study...RecruitingNeoplasms | Breast Cancer | Breast Neoplasms | Breast Diseases | Breast Carcinoma | BRCA1 MutationUnited States
-
Latin American Cooperative Oncology GroupBrazilian Breast Cancer Study Group (GBECAM)Completed
-
Lund University HospitalDanish Breast Cancer Cooperative Group; Swedish Breast Cancer Group; Finnish... and other collaboratorsRecruitingBreast Cancer | Triple Negative Breast NeoplasmsDenmark, Sweden
-
German Breast GroupGerman Adjuvant Breast Cancer GroupCompleted
-
Kyungpook National University Chilgok HospitalKorean Breast Cancer Study GroupNot yet recruitingLymphatic Metastasis | Breast Neoplasm Female
-
Korea University Anam HospitalNational Cancer Center, Korea; Korean Breast Cancer Study GroupUnknownBreast Neoplasms | Genotype | Tamoxifen | CYP2D6Korea, Republic of
-
Norwegian Breast Cancer GroupCompletedBreast NeoplasmNorway
-
Finnish Breast Cancer GroupCompletedImprove Quality of Life | Prevent Osteoporosis and Osteoporotic Fractures | Improve Weight Control, and Muscular and Cardiovascular Fitness | Help the Patients to Return to Working Life | Reduce the Risk of Breast Cancer Recurrence | Reduce All-cause Mortality in Patients With Primary Breast...Finland
-
Finnish Breast Cancer GroupCompleted